The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Rapid Response Innovation Awards, 2009Crystal Structure of Alpha-Synuclein; Toward Rational Drug Design
Objective/Rationale: The alpha-synuclein is implicated in the pathogenesis of Parkinson’s disease. An aggregated form of synuclein containing many molecules has been proposed to interact destructively...
-
Rapid Response Innovation Awards, 2009Probing the Neuroprotective Effects of Haploinsufficiency of RanBP2 in Neurotoxicant-induced Experimental Pre-clinical Models of Parkinson's Disease
Objective/Rationale:
A partial deficit in the level of Ran-binding protein-2 (RanBP2) confers neuroprotection to neurons upon aging and deleterious stimuli promoting oxidative stress, a stress... -
Rapid Response Innovation Awards, 2009Identification of Substrates and Development of a Cell Based Assay for LRRK2
Objective/Rationale:
Inherited mutations in a gene called LRRK2 have recently been discovered to cause Parkinson’s disease. The LRRK2 gene encodes an enzyme called a kinase, which is more active when... -
MJFF Research Grant, 2009PD Pre-clinical Model Repository
Objective/Rationale:
The Michael J. Fox Foundation (MJFF) is partnering with The Jackson Laboratory (JAX) to distribute pre-clinical models of Parkinson’s disease (PD). MJFF funding will allow JAX to... -
Rapid Response Innovation Awards, 2009Phase I Trial of Phenylbutyrate to Prevent Progression of Parkinson's Disease
Objective/Rationale:
Parkinson’s disease gets worse over many years because dopamine neurons continue to die. Researchers have discovered a drug that prevents brain deterioration in pre-clinical... -
Rapid Response Innovation Awards, 2009Aldehyde Dehydrogenase Activators as Novel Drugs For the Treatment of PD
Objective/Rationale:
The accumulation of at least two toxic products in the brain called DOPAL and 4HNE results in death of neurons that are implicated in Parkinson’s Disease (PD). We identified a...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.